Inhibition of phosphatidylinositol kinase by toyocamycin

Hiroshi Nishioka, Tsutomu Sawa, Masa Hamada, Naomi Shimura, Masaya Imoto, Kazuo Umezawa

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)


We have screened toyocamycin as an inhibitor of phosphatidylinositol kinase. It inhibited the enzyme of A431 cell membrane with an IC50 of 3.3 μg/ml. Adenosine and formycin A also inhibited the enzyme, but other 6 related nucleosides did not. Although orobol and 2,3-dihydroxybenzaldehyde that inhibit phosphatidylinositol kinase inhibited in situ phosphatidylinositol turnover, toyocamycin did not.

Original languageEnglish
Pages (from-to)1586-1589
Number of pages4
JournalThe Journal of Antibiotics
Issue number12
Publication statusPublished - 1990

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Inhibition of phosphatidylinositol kinase by toyocamycin'. Together they form a unique fingerprint.

Cite this